Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
May-2014 Volume 9 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2014 Volume 9 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Hesperetin attenuates mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2 cardiomyocytes

  • Authors:
    • Zheng Yang
    • Yuan Liu
    • Wei Deng
    • Jia Dai
    • Fangfang Li
    • Yuan Yuan
    • Qingqing Wu
    • Heng Zhou
    • Zhouyan Bian
    • Qizhu Tang
  • View Affiliations / Copyright

    Affiliations: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China
  • Pages: 1941-1946
    |
    Published online on: March 4, 2014
       https://doi.org/10.3892/mmr.2014.2002
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Apoptosis is closely associated with the occurrence and development of cardiovascular diseases and is considered as one of the crucial pathological processes of cardiomyopathy, sepsis, ischemia/reperfusion injury, myocardial infarction and heart failure. Hesperetin (HES), a flavanone glycoside found in citrus fruit peels, has been known to exhibit several key biological and pharmacological properties. Previous studies have demonstrated the anti-inflammatory, anti-oxidant and anti-tumor functions of HES. However, with regards to the pro- or anti-apoptotic functions of HES, there are several disagreements within the literature. To examine whether HES has protective effects in cardiac apoptosis, the present study examined the role of HES in lipopolysaccharide (LPS)-stimulated H9C2 cardiomyocytes, aiming to clarify the possible mechanisms underlying its effects. In the present study, HES reduced the percentage of viable apoptotic (VA) cells in a flow cytometry analysis. It had an anti-apoptosis function in LPS-stimulated H9C2 cells. To clarify whether HES alleviated LPS-stimulated apoptosis through the mitochondria-dependent intrinsic apoptotic pathway, certain indicators of this pathway were detected, including members of the caspase family. The data revealed that HES attenuated the activation of capase-3 and caspase-9. These results indicated HES has a mitochondria-dependent anti-apoptosis effect in LPS-stimulated H9C2 cells. To explore the possible mechanisms, the protein expression levels of certain markers in the possible signaling pathway were detected, including JNK and Bcl-2 family. As a result, HES downregulated the protein expression of Bax, upregulated the expression of Bcl-2 and attenuated the phosphorylation level of JNK. Therefore, the anti-apoptosis effects of HES were possibly mediated by the JNK/Bax signaling pathway. In conclusion, HES has a mitochondria-dependent anti-apoptosis effect in LPS-induced H9C2 cells via the JNK/Bax signaling pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Marcus FI, Edson S and Towbin JA: Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians. J Am Coll Cardiol. 61:1945–1948. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Sanbe A: Dilated cardiomyopathy: a disease of the myocardium. Biol Pharm Bull. 36:18–22. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Buerke U, Carter JM, Schlitt A, Russ M, Schmidt H, Sibelius U, Grandel U, Grimminger F, Seeger W, Mueller-Werdan U, Werdan K and Buerke M: Apoptosis contributes to septic cardiomyopathy and is improved by simvastatin therapy. Shock. 29:497–503. 2008. View Article : Google Scholar : PubMed/NCBI

4 

Lu D, Ma Y, Zhang W, Bao D, Dong W, Lian H, Huang L and Zhang L: Knockdown of cytochrome P450 2E1 inhibits oxidative stress and apoptosis in the cTnT(R141W) dilated cardiomyopathy transgenic mice. Hypertension. 60:81–89. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Westermann D, Savvatis K, Lindner D, Zietsch C, Becher PM, Hammer E, Heimesaat MM, Bereswill S, Völker U, Escher F, Riad A, Plendl J, Klingel K, Poller W, Schultheiss HP and Tschöpe C: Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy. Circulation. 124:2082–2093. 2011. View Article : Google Scholar

6 

Consoli C, Gatta L, Iellamo F, Molinari F, Rosano GM and Marlier LN: Severity of left ventricular dysfunction in heart failure patients affects the degree of serum-induced cardiomyocyte apoptosis. Importance of inflammatory response and metabolism. Int J Cardiol. 167:2859–2866. 2013. View Article : Google Scholar

7 

Loughran JH, Chugh AR, Ismail I and Bolli R: Stem cell therapy: promising treatment in heart failure? Curr Heart Fail Rep. 10:73–80. 2013. View Article : Google Scholar : PubMed/NCBI

8 

Carneiro AV: Drug therapy for chronic heart failure due to left ventricular systolic dysfunction: a scientific review. I. Introduction. Rev Port Cardiol. 27:851–856. 2008.(In Portuguese).

9 

Tang WH and Huang Y: Cardiotonic modulation in heart failure: insights from traditional Chinese medicine. J Am Coll Cardiol. 62:1073–1074. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Beadle R and Williams L: Device therapy in hypertrophic cardiomyopathy. Expert Rev Cardiovasc Ther. 8:1767–1775. 2010. View Article : Google Scholar : PubMed/NCBI

11 

Del Corsso C and Campos de Carvalho AC: Cell therapy in dilated cardiomyopathy: from animal models to clinical trials. Braz J Med Biol Res. 44:388–393. 2011.PubMed/NCBI

12 

Wang J, Zhu H, Yang Z and Liu Z: Antioxidative effects of hesperetin against lead acetate-induced oxidative stress in rats. Indian J Pharmacol. 45:395–398. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Deng W, Jiang D, Fang Y, Zhou H, Cheng Z, Lin Y, Zhang R, Zhang J, Pu P, Liu Y, Bian Z and Tang Q: Hesperetin protects against cardiac remodelling induced by pressure overload in mice. J Mol Histol. 44:575–585. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Kumar B, Gupta SK, Srinivasan BP, Nag TC, Srivastava S and Saxena R: Hesperetin ameliorates hyperglycemia induced retinal vasculopathy via anti-angiogenic effects in experimental diabetic rats. Vascul Pharmacol. 57:201–107. 2012. View Article : Google Scholar : PubMed/NCBI

15 

Kumar B, Gupta SK, Srinivasan BP, Nag TC, Srivastava S, Saxena R and Jha KA: Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats. Microvasc Res. 87:65–74. 2013. View Article : Google Scholar : PubMed/NCBI

16 

Sambantham S, Radha M, Paramasivam A, Anandan B, Malathi R, Chandra SR and Jayaraman G: Molecular mechanism underlying hesperetin-induced apoptosis by in silico analysis and in prostate cancer PC-3 cells. Asian Pac J Cancer Prev. 14:4347–4352. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Morikawa K, Nonaka M, Mochizuki H, Handa K, Hanada H and Hirota K: Naringenin and hesperetin induce growth arrest, apoptosis, and cytoplasmic fat deposit in human preadipocytes. J Agric Food Chem. 56:11030–11037. 2008. View Article : Google Scholar : PubMed/NCBI

18 

Yang S, Li R, Qu X, Tang L, Ge G, Fang W, Qiao Z, Ma J, Hou Y and Liu H: Fosinoprilat alleviates lipopolysaccharide (LPS)-induced inflammation by inhibiting TLR4/NF-κB signaling in monocytes. Cell Immunol. 284:182–186. 2013.PubMed/NCBI

19 

Guo C, Hou GQ, Li XD, Xia X, Liu DX, Huang DY and Du SX: Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells. Cell Physiol Biochem. 30:123–136. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Niu L, Qiao W, Li G, Li Q, Huang Q, Gong J, Zhu W, Li N and Li J: Different alterations in rat intestinal glutamine transport during the progression of CLP- and LPS-induced sepsis. J Surg Res. 169:284–291. 2011. View Article : Google Scholar : PubMed/NCBI

21 

Lei L, Wang J, Zhang Z, Zhang H, Chen H and Cai D: Lipopolysaccharide-induced apoptosis in a murine intestinal endocrine cell line by modulation of Bcl-2, Bax and caspase-3. Mol Med Rep. 8:1649–1654. 2013.PubMed/NCBI

22 

Sears SF, Woodrow L, Cutitta K, Ford J, Shea JB and Cahill J: A patient’s guide to living confidently with chronic heart failure. Circulation. 127:e525–e528. 2013.

23 

Paraskevaidis I, Palios J, Parissis J, Filippatos G and Anastasiou-Nana M: Treating depression in coronary artery disease and chronic heart failure: what’s new in using selective serotonin re-uptake inhibitors? Cardiovasc Hematol Agents Med Chem. 10:109–115. 2012.

24 

Fujita T and Ishikawa Y: Apoptosis in heart failure. -The role of the β-adrenergic receptor-mediated signaling pathway and p53-mediated signaling pathway in the apoptosis of cardiomyocytes. Circ J. 75:1811–1818. 2011.

25 

Peng Z, Wang H, Zhang R, Chen Y, Xue F, Nie H, Chen Y, Wu D, Wang Y, Wang H and Tan Q: Gastrodin ameliorates anxiety-like behaviors and inhibits IL-1beta level and p38 MAPK phosphorylation of hippocampus in the rat model of posttraumatic stress disorder. Physiol Res. 62:537–545. 2013.PubMed/NCBI

26 

Yuk TH, Kang JH, Lee SR, Yuk SW, Lee KG, Song BY, Kim CH, Kim DW, Dong IK, Lee TK and Lee CH: Inhibitory effect of Carthamus tinctorius L. seed extracts on bone resorption mediated by tyrosine kinase, COX-2 (cyclooxygenase) and PG (prostaglandin) E2. Am J Chin Med. 30:95–108. 2002. View Article : Google Scholar : PubMed/NCBI

27 

Choi EM and Lee YS: Effects of hesperetin on the production of inflammatory mediators in IL-1beta treated human synovial cells. Cell Immunol. 264:1–3. 2010. View Article : Google Scholar : PubMed/NCBI

28 

Dong M, Hu N, Hua Y, Xu X, Kandadi MR, Guo R, Jiang S, Nair S, Hu D and Ren J: Chronic Akt activation attenuated lipopolysaccharide-induced cardiac dysfunction via Akt/GSK3β-dependent inhibition of apoptosis and ER stress. Biochim Biophys Acta. 1832:848–863. 2013.PubMed/NCBI

29 

Wang XL, Wang X, Xiong LL, Zhu Y, Chen HL, Chen JX, Wang XX, Li RL, Guo ZY, Li P and Jiang W: Salidroside improves doxorubicin-induced cardiac dysfunction by suppression of excessive oxidative stress and cardiomyocyte apoptosis: doxorubicin cardiotoxicity inhibited by salidroside. J Cardiovasc Pharmacol. 62:512–523. 2013. View Article : Google Scholar

30 

Mairuae N, Hall Ii EC, Cheepsunthorn P, Lee SY and Connor JR: The H63D HFE gene variant promotes activation of the intrinsic apoptotic pathway via mitochondria dysfunction following β-amyloid peptide exposure. J Neurosci Res. 88:3079–3089. 2010.PubMed/NCBI

31 

Chai WS, Zhu XM, Li SH, Fan JX and Chen BY: Role of Bcl-2 family members in caspase-3/9-dependent apoptosis during Pseudomonas aeruginosa infection in U937 cells. Apoptosis. 13:833–843. 2008. View Article : Google Scholar : PubMed/NCBI

32 

Chen M, Guerrero AD, Huang L, Shabier Z, Pan M, Tan TH and Wang J: Caspase-9-induced mitochondrial disruption through cleavage of anti-apoptotic BCL-2 family members. J Biol Chem. 282:33888–33895. 2007. View Article : Google Scholar : PubMed/NCBI

33 

Barrezueta LF, Oshima CT, Lima FO, De Oliveira Costa H, Gomes TS, Neto RA and De Franco MF: The intrinsic apoptotic signaling pathway in gastric adenocarcinomas of Brazilian patients: Immunoexpression of the Bcl-2 family (Bcl-2, Bcl-x, Bak, Bax, Bad) determined by tissue microarray analysis. Mol Med Rep. 3:261–267. 2010. View Article : Google Scholar

34 

Zhai CL, Zhang MQ, Zhang Y, Xu HX, Wang JM, An GP, Wang YY and Li L: Glycyrrhizin protects rat heart against ischemia-reperfusion injury through blockade of HMGB1-dependent phospho-JNK/Bax pathway. Acta Pharmacol Sin. 33:1477–1487. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Yang Z, Liu Y, Deng W, Dai J, Li F, Yuan Y, Wu Q, Zhou H, Bian Z, Tang Q, Tang Q, et al: Hesperetin attenuates mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2 cardiomyocytes. Mol Med Rep 9: 1941-1946, 2014.
APA
Yang, Z., Liu, Y., Deng, W., Dai, J., Li, F., Yuan, Y. ... Tang, Q. (2014). Hesperetin attenuates mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2 cardiomyocytes. Molecular Medicine Reports, 9, 1941-1946. https://doi.org/10.3892/mmr.2014.2002
MLA
Yang, Z., Liu, Y., Deng, W., Dai, J., Li, F., Yuan, Y., Wu, Q., Zhou, H., Bian, Z., Tang, Q."Hesperetin attenuates mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2 cardiomyocytes". Molecular Medicine Reports 9.5 (2014): 1941-1946.
Chicago
Yang, Z., Liu, Y., Deng, W., Dai, J., Li, F., Yuan, Y., Wu, Q., Zhou, H., Bian, Z., Tang, Q."Hesperetin attenuates mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2 cardiomyocytes". Molecular Medicine Reports 9, no. 5 (2014): 1941-1946. https://doi.org/10.3892/mmr.2014.2002
Copy and paste a formatted citation
x
Spandidos Publications style
Yang Z, Liu Y, Deng W, Dai J, Li F, Yuan Y, Wu Q, Zhou H, Bian Z, Tang Q, Tang Q, et al: Hesperetin attenuates mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2 cardiomyocytes. Mol Med Rep 9: 1941-1946, 2014.
APA
Yang, Z., Liu, Y., Deng, W., Dai, J., Li, F., Yuan, Y. ... Tang, Q. (2014). Hesperetin attenuates mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2 cardiomyocytes. Molecular Medicine Reports, 9, 1941-1946. https://doi.org/10.3892/mmr.2014.2002
MLA
Yang, Z., Liu, Y., Deng, W., Dai, J., Li, F., Yuan, Y., Wu, Q., Zhou, H., Bian, Z., Tang, Q."Hesperetin attenuates mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2 cardiomyocytes". Molecular Medicine Reports 9.5 (2014): 1941-1946.
Chicago
Yang, Z., Liu, Y., Deng, W., Dai, J., Li, F., Yuan, Y., Wu, Q., Zhou, H., Bian, Z., Tang, Q."Hesperetin attenuates mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2 cardiomyocytes". Molecular Medicine Reports 9, no. 5 (2014): 1941-1946. https://doi.org/10.3892/mmr.2014.2002
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team